Bendele A, Seely J, Richey C, Sennello G, Shopp G
Amgen Inc., Boulder, Colorado 80301, USA.
Toxicol Sci. 1998 Apr;42(2):152-7. doi: 10.1006/toxs.1997.2396.
During toxicologic evaluation of a dimeric PEG-linked protein, tumor necrosis factor binding protein (TNF-bp), vacuolation of renal cortical tubular epithelium was seen in male and female Sprague-Dawley rats (200-300 g) given i.v. doses of 40, 20, or 10 mg/kg every other day for 3 months. Tubular lesions in rats treated with 20 or 40 mg/kg for 3 months were only partially reversible after a 2-month recovery period. Despite the presence of marked vacuolation, there were no changes in BUN, creatinine, urinalysis parameters, urinary NAG, urinary B2-microglobulin, or fractional sodium excretion. Single i.v. doses > or = 20 mg/kg TNF-bp caused similar but milder changes. However, equivalent doses of PEG alone or the non-PEG-linked TNF-bp did not cause light microscopic evidence of vacuolation. Treatment of rats with another PEG-linked protein of similar molecular weight resulted in similar changes. Immunostaining for TNF-bp revealed positivity in the apical cytoplasm of renal tubular epithelium within 1 h of i.v. dosing. Immunostaining of kidneys from chronically dosed rats indicated that protein was present in some vacuoles as long as dosing continued; however, kidneys from animals on a reversibility study had vacuoles but no immunostaining for TNF-bp. These results, along with a study that showed more severe lesions with PEG-linked proteins of lower molecular weight and minimal if any lesions with PEG-linked proteins > 70 kDa, suggest that TNF-bp is filtered through the glomerulus and that the protein with attached PEG is reabsorbed by the proximal tubules. Vacuolation may be a result of fluid distension of lysosomes due to the hygroscopic nature of PEG. These studies demonstrated that PEG-linked proteins have the capacity to induce renal tubular vacuolation at high doses. However, the change was not associated with alteration of clinical pathology or functional markers.
在对一种二聚体聚乙二醇连接蛋白——肿瘤坏死因子结合蛋白(TNF-bp)进行毒理学评估期间,体重200 - 300克的雄性和雌性斯普拉格-道利大鼠静脉注射剂量为40、20或10毫克/千克,每隔一天给药一次,持续3个月,结果发现肾皮质肾小管上皮出现空泡化。用20或40毫克/千克剂量治疗3个月的大鼠,在2个月的恢复期后,肾小管损伤仅部分可逆。尽管存在明显的空泡化,但血尿素氮、肌酐、尿液分析参数、尿N-乙酰-β-D-氨基葡萄糖苷酶、尿β2-微球蛋白或钠排泄分数均无变化。静脉注射单剂量≥20毫克/千克的TNF-bp会引起类似但较轻的变化。然而,同等剂量的聚乙二醇单独使用或未与聚乙二醇连接的TNF-bp并不会引起光学显微镜下的空泡化迹象。用另一种分子量相似的聚乙二醇连接蛋白治疗大鼠也会产生类似变化。静脉注射给药1小时内,对TNF-bp进行免疫染色显示肾小管上皮顶端细胞质呈阳性。对长期给药大鼠的肾脏进行免疫染色表明,只要给药持续,一些空泡内就存在蛋白质;然而,进行可逆性研究的动物的肾脏虽有空泡,但对TNF-bp无免疫染色。这些结果,连同一项研究表明分子量较低的聚乙二醇连接蛋白会导致更严重的损伤,而分子量>70 kDa的聚乙二醇连接蛋白即使有损伤也很轻微,提示TNF-bp可通过肾小球滤过,且连接有聚乙二醇的蛋白会被近端小管重吸收。空泡化可能是由于聚乙二醇的吸湿性导致溶酶体液体膨胀的结果。这些研究表明,聚乙二醇连接蛋白在高剂量时能够诱导肾小管空泡化。然而,这种变化与临床病理学或功能标志物的改变无关。